Salomon & Ludwin’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
Other funds holding HRMY
Salomon & Ludwin's HRMY Position: Q3 2026 in Review
Salomon & Ludwin held its Harmony Biosciences (HRMY) position steady in Q3 2026 at 486 shares worth $19.1K. The position accounts for ﹤0.01% of the portfolio, ranked #979.
Salomon & Ludwin first reported a position in HRMY in Q3 2025 and has held it in 5 quarters since. 353 funds tracked by Wall St. Rank hold HRMY as of Q3 2026.
- Salomon & Ludwin held 486 shares of Harmony Biosciences worth $19.1K as of Q3 2026.
- Salomon & Ludwin left its Harmony Biosciences share count unchanged in Q3 2026.
- Harmony Biosciences made up ﹤0.01% of Salomon & Ludwin's portfolio in Q3 2026, its #979 holding.
- Salomon & Ludwin first reported a position in Harmony Biosciences in Q3 2025 and has held it in 5 quarters since.
- 353 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2026.
Based on Salomon & Ludwin's 13F filing for Q3 2026, filed 29 Oct 2026.